NCT06918197

Brief Summary

The purpose of this study is to compare both techniques and analyze the data from the "Standard" technique to help design the "PAS" technique. In the "PAS" technique, investigators predetermine the distances from the needles and place them all together using our initial target needle marker in the objective anatomic landmark. Will randomized patients assigning them either in cohort 1 control "Standard" of care technique and cohort 2 "PAS" technique. After only utilizing the "Standard" of care technique, will obtain the measurements and distances from the needles inserted in patients under fluoroscopic guidance for the different pain procedures. The data will help demonstrate that is possible to predict the needle placement replicating with confidence good outcomes using the "PAS" technique to reduce the radiation exposure and time. Our data will justify the use of the "PAS" technique to become an alternative to the "Standard" of care technique for a faster, efficient, and replicable needle placement for diminished radiation exposure, to avoid complications and consistent good outcomes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
212

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 3, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 9, 2025

Completed
Last Updated

April 9, 2025

Status Verified

April 1, 2025

Enrollment Period

8 months

First QC Date

November 3, 2024

Last Update Submit

April 6, 2025

Conditions

Keywords

SpinePAS

Outcome Measures

Primary Outcomes (3)

  • Radiation Exposure

    Examined Radiation Exposure amount from Fluoroscopic Guidance on Patient

    through study completion, an average of 6 months

  • Radiation Exposure

    radiation exposure from the fluoroscopy dosage logbook

    During the index procedure (from first fluoroscopy activation to last activation on Day 0; ≤ 20 min)

  • Procedure length in time

    Total Procedure Time

    During the index procedure (from anesthesia induction to application of the final bandage after injection on Day 0; measured in minutes)

Secondary Outcomes (1)

  • Numeric Pain Scale

    through study completion, an average of 6 months

Study Arms (2)

Standard Technique

ACTIVE COMPARATOR

Standard Technique is the standard protocol for the pain management procedures completed in this study such as Medical Branch Block, Radiofrequency Ablation, Sacroiliac Joint Block, and Transforaminal Epidural

Procedure: Standard Technique

PAS Technique

EXPERIMENTAL

PAS Technique Protocol: The following steps outline the PAS Technique. While the example below uses 6 injection sites, the approach can be adapted for different pain management procedures with a different number of needle injection sites as needed. Timer: Begin stopwatch for entire procedure from start to medication insertion. Positioning: The patient is placed in a prone position on the fluoroscopic table. Time out was performed. Skin Preparation: Clean the injection site with an antiseptic solution and drape it to maintain sterility. Anesthesia: Administer intravenous sedation Identification of Anatomical Landmark:The spinous process was located and marked as the reference point (SP), which was then used as a guide for the following steps. Marking Target Points: Using the spinous process (SP) as the anatomical landmark and X-ray guided fluoroscopy, Target Point 1 (TP1) was identified and its position verified. The X value (the horizontal distance from the SP to TP1) was measured.

Procedure: PAS Technique

Interventions

PAS TechniquePROCEDURE

PAS Technique Protocol: The following steps outline the PAS Technique. While the example below uses 6 injection sites, the approach can be adapted for different pain management procedures with a different number of needle injection sites as needed. Timer: Begin stopwatch for entire procedure from start to medication insertion. Positioning: The patient is placed in a prone position on the fluoroscopic table. Time out was performed. Skin Preparation: Clean the injection site with an antiseptic solution and drape it to maintain sterility. Anesthesia: Administer intravenous sedation Identification of Anatomical Landmark:The spinous process was located and marked as the reference point (SP), which was then used as a guide for the following steps. Marking Target Points: Using the spinous process (SP) as the anatomical landmark and X-ray guided fluoroscopy, Target Point 1 (TP1) was identified and its position verified. The X value (the horizontal distance from the SP to TP1) was measured.

PAS Technique

In the "Standard" or "Traditional "technique, the spinal needles are used to localize the anatomical objective using fluoroscopic guidance for each needle placement. Traditionally, each needle is placed individually with a spot radiological view before placement and after placement of each needle to confirm the localization.

Standard Technique

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients aged 19 and older
  • No history of:
  • Convictions
  • Infections
  • Cancer
  • Contraindications for surgical procedures
  • Patients scheduled for pain injections who:
  • Agree to participate in the study
  • Sign informed consent and IRB approval consent
  • Complete preoperative, postoperative, and 1-week postoperative questionnaires
  • Patients with chronic lower back pain (lasting over three months) that has not responded to conventional treatments (e.g., NSAIDs, back muscle strengthening, physiotherapy)
  • Symptoms indicating facet pain, including:
  • Lower back pain with or without radiation to the buttocks, thigh, or groin
  • Pain increasing on hyperextension
  • Pain during initial movements
  • +9 more criteria

You may not qualify if:

  • Evidence of:
  • Infection (elevated WBC \>12,000 or UTI)
  • Neoplastic disease
  • Possible pregnancy, bleeding diathesis, or anticoagulant therapy
  • History of sensitivity to local anesthetics
  • \*\*Preoperative and Postoperative Assessments:\*\*
  • Visual Analog Scale (VAS)
  • Numeric Pain Scale
  • Disability Oswestry Index questionnaires
  • Additional data collection for both cohorts:
  • Patient demographics (age, gender, race, height, weight, BMI)
  • Radiation exposure from fluoroscopy (in mGy)
  • Procedure duration
  • Horizontal and vertical distance measurements (in cm) between spinal needle placements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Surgery Center

Merced, California, 95340, United States

Location

Related Publications (1)

  • Patel K, Chopra P, Martinez S, Upadhyayula S. Epidural Steroid Injections. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK470189/

    PMID: 29262183BACKGROUND

Related Links

MeSH Terms

Conditions

Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mary Oster, Metrowest IRB Chair

    Metro West Medical Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopedic Spinal Surgeon, Principal Investigator

Study Record Dates

First Submitted

November 3, 2024

First Posted

April 9, 2025

Study Start

October 1, 2023

Primary Completion

May 15, 2024

Study Completion

May 15, 2024

Last Updated

April 9, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Investigators have no reason to disclose participant data but if requested, investigators will share data using the correct necessary steps protecting patient privacy.

Locations